Nuvectis Pharma
NVCT
NVCT
11 hedge funds and large institutions have $7.2M invested in Nuvectis Pharma in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
2
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
RC
Ronit Capital
London,
United Kingdom
|
$4.7M |
| 2 |
Millennium Management
New York
|
$0 |
| 3 |
VF
Virtu Financial
New York
|
$0 |
| 4 |
BlackRock
New York
|
$80K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
$14K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
RC
1
Ronit Capital
London,
United Kingdom
| $4.7M | -$1.46M | -130,718 | -24% |
|
|
BWP
2
Baldwin Wealth Partners
Marion,
Massachusetts
| $1.36M | +$1.36M | +121,000 | New |
|
3
Citadel Advisors
Miami,
Florida
| $393K | +$393K | +35,069 | New |
|
4
Geode Capital Management
Boston,
Massachusetts
| $268K | +$102K | +9,145 | +62% |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $261K | +$261K | +23,257 | New |
|
6
State Street
Boston,
Massachusetts
| $131K | +$131K | +11,700 | New |
|
|
7
BlackRock
New York
| $80K | -$7.49K | -674 | -9% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $14K | -$5.16K | -471 | -27% |
|
9
Morgan Stanley
New York
| $2K | +$2K | +200 | New |
|
10
UBS Group
Zurich,
Switzerland
| $1K | -$1.27K | -79 | -56% |
|
|
11
Millennium Management
New York
| – | -$312K | -42,160 | Closed |
|
|
VF
12
Virtu Financial
New York
| – | -$84K | -11,365 | Closed |
|